AXIOS: Drugmaker tripled the price of a pill as it pursued coronavirus use
"The price hike coincides with the company's push to get its drug to more patients — specifically those diagnosed with COVID-19."
It’s a lot for me to manage.
There was a point where I was in so much discomfort that I paid $60 for just a couple of packets, but I could never afford the full dose my doctor prescribed.
Drug Corporations Didn’t Invest in Vaccines Until a Global Pandemic
Drug companies only showed interest in COVID-19 vaccines and treatments when huge profits arose.
COVID-19: Why Drug Corporations didn’t invest in vaccines until a global pandemic
As the COVID-19 crisis grows, Big Pharma is trying to position itself as the key to ending this pandemic. But drug corporations have been uninterested in fighting infectious diseases for decades.
The cost was just too high.
If I were prescribed a drug like Onglyza again, I would have to use a credit card to pay for it, and I would go into debt.
Statement: Public-Private Partnership to Drive COVID-19 Research Overlooks Drug Prices
The federal government will be the single largest investor and the largest purchaser of an upcoming COVID-19 vaccine or treatment.
I worry constantly.
Patients like me have worked all our lives in hopes of a peaceful and enjoyable retirement.
Tracking COVID-19 Funds: How U.S. Taxpayers Are Investing in Vaccines and Treatments
In just one week, U.S. taxpayers gave more than $700 million to pharma for COVID-19 research and development.
